BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Berdowska I, Matusiewicz M. Cathepsin L, transmembrane peptidase/serine subfamily member 2/4, and other host proteases in COVID-19 pathogenesis – with impact on gastrointestinal tract. World J Gastroenterol 2021; 27(39): 6590-6600 [PMID: 34754154 DOI: 10.3748/wjg.v27.i39.6590]
URL: https://www.wjgnet.com/1948-9358/full/v27/i39/6590.htm
Number Citing Articles
1
Ya-Chieh Chang, Ding-Jie Lee, Chia-Ling Helen Wei, Chung-Han Pa, Chien-Chou Chen, Hsi-Chih Chen, Yu-Tien Chang, Han-En Wang, Pauling Chu, Kuo‐cheng Lu, Chia-Chao Wu. SARS-CoV-2 versus other minor viral infection on kidney injury in asymptomatic and mildly symptomatic patientsVirulence 2022; 13(1): 1349 doi: 10.1080/21505594.2022.2107602
2
Camelia Bhattacharyya, Surupa Chakraborty, Rajib Sengupta. NO news: S-(de)nitrosylation of cathepsins and their relationship with cancerAnalytical Biochemistry 2022; 655: 114872 doi: 10.1016/j.ab.2022.114872
3
Rajiv Gandhi Govindaraj, Sundar Thangapandian, Michael Schauperl, Rajiah Aldrin Denny, David J. Diller. Recent applications of computational methods to allosteric drug discoveryFrontiers in Molecular Biosciences 2023; 9 doi: 10.3389/fmolb.2022.1070328
4
Shaoshuai Li, Yang Zhou, Dongmei Yan, Yanmin Wan. An Update on the Mutual Impact between SARS-CoV-2 Infection and Gut MicrobiotaViruses 2022; 14(8): 1774 doi: 10.3390/v14081774
5
Mei-Chi Chang, Jen-Hao Chen, Hui-Na Lee, Shyuan-Yow Chen, Bor-Hao Zhong, Kunaal Dhingra, Yu-Hwa Pan, Hsiao-Hua Chang, Yi-Jane Chen, Jiiang-Huei Jeng. Inducing cathepsin L expression/production, lysosomal activation, and autophagy of human dental pulp cells by dentin bonding agents, camphorquinone and BisGMA and the related mechanismsBiomaterials Advances 2023; 145: 213253 doi: 10.1016/j.bioadv.2022.213253
6
Jeffrey A. Kraut, Izaak J. Cheetham‐Wilkinson, Laura E. Swan, Massimiliano Stagi, Ira Kurtz. Impact of various buffers and weak bases on lysosomal and intracellular pH : Implications for infectivity of SARS‐CoV ‐2 FASEB BioAdvances 2023;  doi: 10.1096/fba.2022-00062